Search

Your search keyword '"Olthof, Pim"' showing total 82 results

Search Constraints

Start Over You searched for: Author "Olthof, Pim" Remove constraint Author: "Olthof, Pim" Database OAIster Remove constraint Database: OAIster
82 results on '"Olthof, Pim"'

Search Results

1. Higher Postoperative Mortality and Inferior Survival After Right-Sided Liver Resection for Perihilar Cholangiocarcinoma: Left-Sided Resection is Preferred When Possible

2. Clinical features and prediction of long-term survival after surgery for perihilar cholangiocarcinoma

Catalog

Books, media, physical & digital resources

3. The Influence of Hepatic Steatosis and Fibrosis on Postoperative Outcomes After Major Liver Resection of Perihilar Cholangiocarcinoma

4. Higher Postoperative Mortality and Inferior Survival After Right-Sided Liver Resection for Perihilar Cholangiocarcinoma:Left-Sided Resection is Preferred When Possible

5. Effect of Sarcopenia on the Increase in Liver Volume and Function After Portal Vein Embolization

7. Prognostic value of Mandard score and nodal status for recurrence patterns and survival after multimodal treatment of oesophageal adenocarcinoma

8. Nationwide treatment and outcomes of intrahepatic cholangiocarcinoma

9. ASO Visual Abstract:The Influence of Hepatic Steatosis and Fibrosis on Postoperative Outcomes After Major Liver Resection of Perihilar Cholangiocarcinoma

10. Nationwide treatment and outcomes of intrahepatic cholangiocarcinoma

11. Hepatobiliary scintigraphy to predict postoperative liver failure after major liver resection; a multicenter cohort study in 547 patients

12. E-AHPBA-ESSO-ESSR Innsbruck consensus guidelines for preoperative liver function assessment before hepatectomy

13. Evaluation of National Surgical Practice for Lateral Lymph Nodes in Rectal Cancer in an Untrained Setting

14. Uptake of robot-assisted colon cancer surgery in the Netherlands

16. Multivariable prediction model for both 90-day mortality and long-term survival for individual patients with perihilar cholangiocarcinoma:does the predicted survival justify the surgical risk?

17. Major complications and mortality after resection of intrahepatic cholangiocarcinoma:A systematic review and meta-analysis

18. Major complications and mortality after resection of intrahepatic cholangiocarcinoma: A systematic review and meta-analysis

19. Trends in Distal Esophageal and Gastroesophageal Junction Cancer Care: The Dutch Nationwide Ivory Study

20. Histopathological growth patterns of neuroendocrine tumor liver metastases

22. Development and internal validation of the Comprehensive ALPPS Preoperative Risk Assessment (CAPRA) score : is the patient suitable for Associating Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS)?

23. Development and internal validation of the Comprehensive ALPPS Preoperative Risk Assessment (CAPRA) score : is the patient suitable for Associating Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS)?

24. Validation study of postoperative liver failure and mortality risk scores after liver resection for perihilar cholangiocarcinoma

25. Validation study of postoperative liver failure and mortality risk scores after liver resection for perihilar cholangiocarcinoma

26. Development and internal validation of the Comprehensive ALPPS Preoperative Risk Assessment (CAPRA) score : is the patient suitable for Associating Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS)?

27. Validation study of postoperative liver failure and mortality risk scores after liver resection for perihilar cholangiocarcinoma

28. Validation study of postoperative liver failure and mortality risk scores after liver resection for perihilar cholangiocarcinoma

29. Sarcopenia predicts reduced liver growth and reduced resectability in patients undergoing portal vein embolization before liver resection - A DRAGON collaborative analysis of 306 patients

30. Increased Hepatic Microvascular Density, Oxygenation, and VEGF in the Hypertrophic Lobe following Portal Vein Embolization in Rabbits

31. Current evidence on posthepatectomy liver failure:comprehensive review

32. Minimally Invasive Liver Surgery:A Snapshot from a Major Dutch HPB and Transplant Center

34. Sarcopenia and long-term survival outcomes after local therapy for colorectal liver metastasis:a meta-analysis

35. Interregional practice variations in the use of local therapy for synchronous colorectal liver metastases in the Netherlands

36. Absence of association between CT-assessed skeletal muscle mass and long-term oncological outcomes after curative therapy for colorectal liver metastasis

37. Sarcopenia predicts reduced liver growth and reduced resectability in patients undergoing portal vein embolization before liver resection-A DRAGON collaborative analysis of 306 patients

38. Development and internal validation of the Comprehensive ALPPS Preoperative Risk Assessment (CAPRA) score : is the patient suitable for Associating Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS)?

39. Development and internal validation of the Comprehensive ALPPS Preoperative Risk Assessment (CAPRA) score : is the patient suitable for Associating Liver Partition and Portal vein ligation for Staged hepatectomy (ALPPS)?

40. Recurrent Disease after Esophageal Cancer Surgery: A Substudy of The Dutch Nationwide Ivory Study

41. Unaltered Liver Regeneration in Post-Cholestatic Rats Treated with the FXR Agonist Obeticholic Acid

42. Unaltered Liver Regeneration in Post-Cholestatic Rats Treated with the FXR Agonist Obeticholic Acid

43. Unaltered Liver Regeneration in Post-Cholestatic Rats Treated with the FXR Agonist Obeticholic Acid

44. Unaltered Liver Regeneration in Post-Cholestatic Rats Treated with the FXR Agonist Obeticholic Acid

45. Unaltered Liver Regeneration in Post-Cholestatic Rats Treated with the FXR Agonist Obeticholic Acid

46. Unaltered Liver Regeneration in Post-Cholestatic Rats Treated with the FXR Agonist Obeticholic Acid

47. Unaltered Liver Regeneration in Post-Cholestatic Rats Treated with the FXR Agonist Obeticholic Acid

48. Actual 10-Year Survival after Resection of Perihilar Cholangiocarcinoma:What Factors Preclude a Chance for Cure?

49. Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma (vol 28, pg 1483, 2021)

50. Nationwide treatment and outcomes of perihilar cholangiocarcinoma